• LAST PRICE
    1.1600
  • TODAY'S CHANGE (%)
    Trending Up0.0100 (0.8696%)
  • Bid / Lots
    1.1600/ 19
  • Ask / Lots
    1.1700/ 53
  • Open / Previous Close
    1.1400 / 1.1500
  • Day Range
    Low 1.1100
    High 1.1900
  • 52 Week Range
    Low 0.9200
    High 4.1700
  • Volume
    188,102
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 1.15
TimeVolumeLPTX
09:32 ET3211.14
09:34 ET253501.1425
09:38 ET77001.13
09:41 ET32051.13
09:43 ET39821.13
09:48 ET3001.15
09:52 ET111651.15
09:54 ET10001.17
09:59 ET13501.16
10:10 ET28951.17
10:12 ET7091.17
10:14 ET1001.17
10:17 ET1001.155
10:24 ET3641.17
10:26 ET64191.185
10:30 ET41301.17
10:32 ET2001.17
10:33 ET13001.17
10:35 ET10001.17
10:39 ET18331.155
10:42 ET4021.16
10:44 ET23821.17
10:50 ET3991.18
10:53 ET17011.17
10:55 ET41391.16
11:00 ET19981.17
11:06 ET32001.17
11:08 ET6001.17
11:09 ET12001.17
11:11 ET23901.18
11:13 ET2301.18
11:18 ET2331.19
11:22 ET1001.19
11:24 ET1001.18
11:26 ET5881.18
11:29 ET1001.17
11:31 ET1581.175
11:33 ET49001.17
11:36 ET3001.16
11:42 ET29751.1601
11:47 ET1001.1653
12:02 ET1001.1686
12:05 ET2001.165
12:07 ET6001.16
12:18 ET57331.16
12:23 ET2001.165
12:27 ET58001.16
12:32 ET1001.1686
12:34 ET1001.165
12:38 ET1001.16
12:39 ET1001.16
12:41 ET2001.16
12:43 ET1001.16
12:45 ET2001.16
12:48 ET4001.16
12:50 ET6001.16
12:52 ET2001.17
12:54 ET2001.16
12:56 ET1001.16
12:57 ET3001.16
01:12 ET3001.16
01:15 ET3001.169
01:24 ET5501.16
01:28 ET1001.165
01:30 ET1001.16
01:32 ET2001.165
01:33 ET7001.165
01:39 ET38401.17
01:53 ET14221.18
01:55 ET40831.185
01:57 ET7781.18
02:00 ET1001.179
02:02 ET1101.175
02:06 ET22121.17
02:08 ET4101.17
02:15 ET12001.17
02:29 ET62001.17
02:31 ET1001.17
02:33 ET21421.175
02:36 ET197981.18
02:45 ET8451.18
02:47 ET21621.175
02:51 ET51001.175
03:00 ET81371.16
03:02 ET2001.16
03:03 ET1001.16
03:07 ET1001.16
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLPTX
Leap Therapeutics Inc
101.6M
-2.1x
---
United StatesSMMT
Summit Therapeutics Inc
98.1M
-1.0x
---
United StatesCKPT
Checkpoint Therapeutics Inc
100.8M
-1.3x
---
United StatesENOB
Enochian Biosciences Inc
102.2M
-2.4x
---
United StatesBCLI
Brainstorm Cell Therapeutics Inc
100.7M
-4.3x
---
United StatesACHL
Achilles Therapeutics PLC
102.7M
-1.5x
---
As of 2022-07-01

Company Information

Leap Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. The Company’s clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. When DKN-01 binds to DKK1, an anti-tumor effect can be generated. DKK1 is a cell secreted protein that research has found its role in embryonic development. DKN-01 is an affinity, neutralizing monoclonal antibody targeting DKK1. DKN-01 reduces free DKK1 levels and has demonstrated an anti-tumor effect in preclinical models.

Contact Information

Headquarters
47 Thorndike St Ste B1-1CAMBRIDGE, MA, United States 02141-1799
Phone
617-252-4343
Fax
302-636-5454

Executives

Chairman of the Board
Christopher Mirabelli
Chief Financial Officer, Treasurer, Secretary, Director
Douglas Onsi
Chief Operating Officer
Augustine Lawlor
Vice President, Head - Regulatory Affairs and Quality
Christine Granfield
Chief Manufacturing Officer
Mark O'Mahony

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$101.6M
Revenue (TTM)
$1.1M
Shares Outstanding
88.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.66
EPS
$-0.55
Book Value
$1.22
P/E Ratio
-2.1x
Price/Sales (TTM)
90.3
Price/Cash Flow (TTM)
---
Operating Margin
-3,812.09%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.